Abstract
A novel protein of 21 kDa (p21) has been detected in the sera of patients with different solid tumors. The serum levels of this p21 protein were measured in seven patients with metastatic testicular germ-cell tumors before and after chemotherapy using an enzyme-linked immunosorbent assay. In five out of six patients who responded to chemotherapy a concomitant decrease of p21 serum levels was found. The decrease of p21 was in accordance with the decline of the established tumor markers α-fetoprotein, human chorionic gonadotropin β-subunit and lactate dehydrogenase in three patients with non-seminomatous tumors and with the decline of lactate dehydrogenase and the clinical response in two patients with seminoma. In one patient the predicted decline of p21 did not occur despite the patient's clinical response to chemotherapy. In the seventh patient, who relapsed directly after chemotherapy, no decline of either p21 levels or tumor markers was observed. The absolute amount of the p21 protein prior to chemotherapy did not correlate with the patients' tumor burden. Elevated levels of p21 were found in patients with seminomatous and non-seminomatous germ-cell tumors. Since seminoma patients do not secrete tumor markers like α-fetoprotein or human chorionic gonadotropin β, the determination of p21 levels may help to evaluate the efficacy of chemotherapy in patients with seminomatous as well as in patients with marker-negative non-seminomatous germ-cell tumors. The biological role of p21 and its clinical significance will be further investigated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Benter T, Grundner-Culemann E, Schmoll HJ, Poliwoda H, Shalitin C, Neubauer V (1991) Nachweis eines 21 kDa Proteins in Sera von Tumorpatienten. Klin Wochenschr [Suppl 23] 96:204
Bokoch GM, Quilliam LA (1990) Guanine nucleotide binding properties ofrap 1 purified from human neutrophils. Biochem J 267:407–411
Bosl GJ, Geller NL, Cirrincione C et al. (1983) serum tumor markers in patients with metastatic germ cell tumors of the testis. Am J Med 75:29–35
Cavalli F, Monfardini S, Pizzocarro G (1980) Report on the international Workshop on Staging and Treatment of Testicular Cancer. Europ J Cancer 16:1367–1372
Chesa PG, Rettig WJ, Melamed MR, Old LJ, Niman HL (1987) Expression of p21ras in normal and malignant human tissues: lack of association with proliferation and malignancy. Proc Natl Acad Sci USA 84:3234–3238
Droz JP, Kramar A, Ghoson M, et al. (1988) Prognostic factors in advanced non-seminomatous testicular cancer. A multivariate logistic regression analysis. Cancer 62:564–568
Einhorn LH (1981) Testicular cancer as a model for a curable neoplasm. The Richard and Hilda Rosenthal Foundation Award lecture. Cancer Res 41:3275–3280
Einhorn LH (1990) Testicular cancer: a new and improved model. J Clin Oncol 8:1777–1781
Grundner-Culemann E, Benter T, Schöffski P, Poliwoda H, Shalitin C, Neubauer V (1992a) Semiquantitative Analyse eines 21 kDa Proteins (p21) bei Patienten mit gastrointestinalen Tumoren unter Chemotherapie. Klin Wochenschr [Suppl 28] 69:78
Grundner-Culemann E, Neubauer V, Schöffski P, Fricke D, Shalitin C, Poliwoda H, Benter T (1992b) Semiquantitative analysis of a 21 kDa protein in liver cancer patients under therapy. Ann Hematol [Suppl 65] A62
Kawata M, Matsui Y, Kondo J, Hishida T, Teranishi Y, Takai Y (1988) A novel small molecular weight GTP-binding protein with the same putative effector domain as theras proteins in bovine brain membranes. Purification, determination of primary structure, and characterization. J Biol Chem 263: 18965–18971
Shalitin C, Epelbaum RE, Valansi C, Segal R, Mekori L, Lorber M, Bartal AH, Robinson E (1990) Detection of a 21 kDa protein in sera of patients with urogenital tumors. Cancer J 3:74–78
Shalitin C, Epelbaum R, Valansi C, Segal R, Mekori T, Lover B, Robinson E (1991) A novel 21 kDa protein as a serum marker for benign and malignant urogenital tumors. Preliminary communication. Int J Cancer 49:861–866
Shalitin C, Epelbaum R, Moskovitz B, Segal R, Valansi C, Mekori T, Lerner M (1992a) Enzyme-linked immunosorbent assay for the detection of a novel 21 kDa protein associated with the clinical course of patients with urogenital tumors. Int J Oncol 1:107–112
Shalitin C, Moskovitz B, Livne PM, Segal R, Nasar S, Bolkier M, Lerner M, Werner M, Valansi C (1992b) Serial levels of p21 before and after surgery in patients with renal cell carcinoma In: Giuliani L, Puppo P (eds) Urology 1992, Monduzzi Editore, Bolognia, Italy, pp 325–329
Stoter G, Sylvester R, Sleijfer D et al. (1987) Multivariate analysis of prognostic factors in patients with disseminated non-seminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer multi-institutional phase-III study. Cancer Res 47:2714–2718
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354
Wessel D, Flügge VI (1984) A method for the qualitative recovery of protein in dilute solution in the presence of detergens and lipids. Anal Biochem 138:141–143
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grundner-Culemann, E., Bokemeyer, C., Neubauer, V. et al. Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumors. J Cancer Res Clin Oncol 119, 685–688 (1993). https://doi.org/10.1007/BF01215988
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01215988